(f) TERMINATION OF INTERDISCIPLINARY REVIEW 
PROCESS FOR NON-NIH-FUNDED RESEARCHERS.—The 
Secretary may not— 
(1) reinstate the Public Health Service inter-
disciplinary review process described in the guidance 
entitled ‘‘Guidance on Procedures for the Provision 
of Marijuana for Medical Research’’ (issued on May 
21, 1999); or 
(2) create an additional review of scientific pro-
tocols that is only conducted for research on mari-
juana other than the review of research protocols 
performed at the request of a researcher conducting 
nonhuman research that is not federally funded, in 
accordance with section 303(f)(3)(A)(ii)(II) of the 
Controlled 
Substances 
Act 
(21 
U.S.C. 
823(f)(3)(A)(ii)(II)), as amended by subsection (d). 
(g) CONSIDERATION OF RESULTS OF RESEARCH.— 
Immediately upon the approval by the Food and Drug Ad-
ministration of an application for a marijuana-based drug 
under section 505 of the Federal Food, Drug, and Cos-
metic Act (21 U.S.C. 355), and (irrespective of whether 
any such approval is granted) not later than the date that 
is 5 years after the date of enactment of this Act, the 
Secretary shall— 
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00043
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
(1) conduct a review of existing medical and 
other research with respect to marijuana; 
(2) submit a report to the Congress on the re-
sults of such review; and 
(3) include in such report whether, taking into 
consideration the factors listed in section 201(c) of 
the Controlled Substances Act (21 U.S.C. 811(c)), 
as well as any potential for medical benefits, any 
gaps in research, and any impacts of Federal restric-
tions and policy on research, marijuana should be 
transferred to a schedule other than schedule I (if 
marijuana has not been so transferred already). 
(h) NO
PRODUCTION
QUOTAS
FOR
MARIJUANA 
GROWN FOR LEGITIMATE, MEDICAL RESEARCH.—Section 
306 of the Controlled Substances Act (21 U.S.C. 826) is 
amended by adding at the end the following: 
‘‘(i) The Attorney General may only establish a quota 
for production of marijuana that is manufactured and dis-
tributed in accordance with the Medical Marijuana Re-
search Act of 2017 that meets the changing medical, sci-
entific, and industrial needs for marijuana.’’. 
(i) ARTICLE 28 OF THE SINGLE CONVENTION ON 
NARCOTIC DRUGS.—Article 28 of the Single Convention 
on Narcotic Drugs shall not be construed to prohibit, or 
impose additional restrictions upon, research involving 
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00044
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
marijuana, or the manufacture, distribution, or dispensing 
of marijuana, that is conducted in accordance with the 
Controlled Substances Act (21 U.S.C. 801 et seq.), this 
section, and the amendments made by this section. 
(j) NO INTERFERENCE BY DEPARTMENT OF JUS-
TICE.—The Attorney General, and any officer or employee 
of the Department of Justice, shall not interfere with the 
production, distribution, and sale of marijuana in accord-
ance with this section and the amendments made by this 
section. 
SEC. 402. PROVISION BY HEALTH CARE PROVIDERS OF THE 
DEPARTMENT OF VETERANS AFFAIRS OF 
RECOMMENDATIONS 
AND 
OPINIONS 
RE-
GARDING 
VETERAN 
PARTICIPATION 
IN 
STATE MARIJUANA PROGRAMS. 
(a) SHORT TITLE.—This section may be cited as the 
‘‘Veterans Equal Access Act of 2017’’. 
(b) AUTHORIZATION.—Notwithstanding any other 
provision of law, the Secretary of Veterans Affairs shall 
authorize physicians and other health care providers em-
ployed by the Department of Veterans Affairs— 
(1) to provide recommendations and opinions to 
veterans who are residents of States with State 
marijuana programs regarding the participation of 
veterans in such State marijuana programs; and 
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00045
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
(2) to complete forms reflecting such rec-
ommendations and opinions. 
SEC. 403. PROVISION BY MEDICAL PROFESSIONALS OF THE 
INDIAN HEALTH SERVICE OF RECOMMENDA-
TIONS AND OPINIONS REGARDING PARTICI-
PATION IN STATE MARIJUANA PROGRAMS. 
(1) IN GENERAL.—Notwithstanding any other 
provision of law, IHS medical professionals are au-
thorized to make medical recommendations to their 
patients with regard to marijuana and to complete 
forms reflecting such recommendations. 
(2) DEFINITIONS.—In this subsection: 
(A) IHS MEDICAL
PROFESSIONAL.—The 
term ‘‘IHS medical professional’’ means a phy-
sician or other health professional furnishing 
services through an Indian health program (as 
defined in section 108(a)(2) of the Indian 
Health Care Improvement Act (25 U.S.C. 
1616a(a)(2))). 
(B) RECOMMENDATIONS.—The term ‘‘rec-
ommendations’’ does not include dispensing (as 
defined in section 102 of the Controlled Sub-
stances Act (21 U.S.C. 802)). 
Æ 
VerDate Sep 11 2014 
03:06 Apr 05, 2017
Jkt 069200
PO 00000
Frm 00046
Fmt 6652
Sfmt 6301
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS